COLO B Coloplast A/S Class B

Coloplast strengthens ostomy care portfolio with three significant product launches

Coloplast strengthens ostomy care portfolio with three significant product launches

The company has received reimbursement approval in the UK for Heylo™, the world’s first digital leakage notification system, and expands its SenSura® Mio ostomy range with two new products.

  • As part of our 2025 strategy, Strive25, we set an ambition to significantly raise the standard of care for our users and bring new products to market at a higher pace. I am excited to see that our Innovation unit continues to deliver on this commitment, latest with these three new products in Ostomy Care, says Executive Vice President of Innovation, Nicolai Buhl.

Introducing Heylo

For many people living with a stoma, leakage is a significant physical and mental challenge in their daily life. Heylo is designed to detect potential leakages under the ostomy baseplate, and by notifying users at an early stage it enables them to take action and prevent the leakage from progressing. The product consists of a sensor layer that is attached to the baseplate, a transmitter that is attached to the sensor layer and connects to the user’s smartphone via Bluetooth®, and an app that notifies the user at the first sign of leakage and if it continues to spread.

  • Heylo is the world’s first digital leakage notification system and a big step forward in providing more personalised care for our users. I believe Heylo will help users feel more in control, bring peace of mind, reduce their fear of leakage, and ultimately improve quality of life, says Nicolai Buhl.

The first market to launch Heylo will be the UK, where national reimbursement has been granted as of 1 July 2024*.

Introducing SenSura® Mio in black and SenSura Mio Convex Soft with Flex coupling

Coloplast is also expanding its SenSura Mio range with two new products. The company is launching SenSura Mio in black, aiming to provide more product choice for people with a stoma.

  • We know that having more product choice matters to people adapting to life after stoma surgery and may even help people in accepting their condition. Black is neutral, discreet, and timeless – and our hope is that this new bag will empower users and give them confidence to live life on their terms, says Nicolai Buhl.

The first variants of the SenSura Mio in black will be introduced in key markets over the next six months, starting with Italy, France, Denmark, Norway, and the Netherlands in May 2024*.

Coloplast is also launching SenSura Mio Convex Soft with Flex coupling to reach more users that need convexity and 2-piece solutions. This product will be introduced in key markets over the next nine months, starting in Italy and France in May 2024*.

Contacts

Peter Mønster

Sr. Media Relations Manager



Aleksandra Dimovska

Sr. Director of Investor Relations



*Heylo, SenSura Mio in black, and SenSura Mio Convex Soft with Flex coupling are medical devices for which CE-mark has been affixed. Product availability is subject to the regulatory process of individual countries and is not guaranteed. These products are currently not available in the US.

Attachments



EN
07/05/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Coloplast A/S Class B

 PRESS RELEASE

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående p...

Coloplast A/S - Bestyrelsesmedlemmers, direktørers eller nærtstående personers handel med Coloplast-aktier Se venligst vedlagte pdf.   Vedhæftet fil

 PRESS RELEASE

Coloplast A/S - Trading in Coloplast shares by board members, executiv...

Coloplast A/S - Trading in Coloplast shares by board members, executives or associated persons Please see enclosed pdf.   Attachment

 PRESS RELEASE

Coloplast udnævner Gavin Wood som ny CEO

Coloplast udnævner Gavin Wood som ny CEO Selskabsmeddelelse nr. 3/2026 Intern viden Coloplast udnævner Gavin Wood som ny CEO Det er med glæde, at Coloplasts bestyrelse kan annoncere udnævnelsen af Gavin Wood som ny CEO fra den 1. maj 2026. Gavin Wood afløser Lars Rasmussen, der har været midlertidig CEO siden den 5. maj 2025. Gavin Wood har i to årtier bestredet forskellige ledelsesroller i Johnson & Johnson, senest som øverste leder for Johnson & Johnson MedTech EMEA, en forretning der omsætter for adskillige milliarder dollars og har mere end 7000 medarbejdere på tværs af tre forretnin...

 PRESS RELEASE

Coloplast appoints Gavin Wood as new CEO

Coloplast appoints Gavin Wood as new CEO Announcement no. 3/2026 Inside information Coloplast appoints Gavin Wood as new CEO The Coloplast Board of Directors is pleased to announce the appointment of Gavin Wood as the new President and Chief Executive Officer (CEO) of the Coloplast Group, effective May 1, 2026. Gavin Wood will take over from interim CEO Lars Rasmussen, who has been in the role since May 5, 2025. Gavin Wood has spent two decades in different leadership roles in Johnson & Johnson, most recently as Company Group Chairman of Johnson & Johnson MedTech EMEA, a multi-billion-do...

 PRESS RELEASE

Coloplast A/S - Updated Financial Calendar 2025-26

Coloplast A/S - Updated Financial Calendar 2025-26 Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.  The updated dates are as follows: Financial Statements for the full year 2025/26 and Annual Report 2025/26: changed from November 5, 2026 to November 3, 2026Annual General Meeting 2026: changed from December 3, 2026 to December 1, 2026 For more information and calendar invitations for upcoming events, please visit:   Kind...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch